A landmark trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose management in adults with type 2 diabetes using basal insulin, outperforming ...

A major clinical trial has found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose ...

When diabetes patients track their blood sugar with a 24-hour wearable device, they manage their glucose more precisely and ...

A major UK clinical trial found that continuous glucose monitoring (CGM) significantly improved blood sugar control in adults with type 2 diabetes using basal insulin, compared to finger-prick testing ...

Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

Apple Watch displays real-time glucose data from CGM devices like the Dexcom G7, while Apple continues to develop ...

The next-generation CGM is now available in Sweden, with launches expected in Germany, Spain and Italy during the coming weeks as part of a phased roll out ...

Continuous glucose monitoring in the GRADE trial shows that incretin-based drugs such as sitagliptin and liraglutide produce the most stable glycemic profiles and show the lowest hypoglycemia risk.

Dexcom G7 CGMs contain a complex electronic assembly within a wearable package that stands up to the rigors of everyday ...

Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one ...